Plasminogen activators and plasminogen activator inhibitor (PAI-1) in type II diabetes mellitus
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Fibrinolysis
- Vol. 4 (3) , 183-188
- https://doi.org/10.1016/s0268-9499(05)80051-7
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- 412 Tissue-type plasminogen activator and plasminogen activator inhibitor in diabetes mellitusFibrinolysis, 1988
- Glycaemic Control, Smoking Habits and Diabetes Duration Affect the Extrinsic Fibrinolytic System in Type I Diabetic Patients but Microangiopathy Does NotActa Medica Scandinavica, 1988
- Diabetes mellitus as a hypercoagulable state: Its relationship with fibrin fragments and vascular damageThrombosis Research, 1987
- Decreased protein C levels in patients with insulin-dependent type I diabetes mellitusDiabetes, 1986
- Platelet and coagulation factors in proliferative diabetic retinopathy.Journal of Clinical Pathology, 1984
- Endothelial factors in relation to peripheral circulation in diabeticsThrombosis Research, 1980
- Changes of fibrinolysis and factor VIII coagulant, antigen, and ristocetin cofactor in diabetes mellitus and atherosclerosisThrombosis Research, 1980
- Decreased Vascular Prostacyclin in Juvenile-Onset DiabetesNew England Journal of Medicine, 1979
- Plasma Cofactors of Platelet Function: Correlation with Diabetic Retinopathy and Hemoglobins Ala-cAnnals of Internal Medicine, 1978
- Synthesis of fibrinolytic activator and inhibitor by endothelial cellsProceedings of the National Academy of Sciences, 1977